Drug-induced hypertension

Journal of Clinical Hypertension

Volumn 5, Issue 1, 2003, Pages 83-85

  Handler, Joel ^a  

^a KAISER PERMANENTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; AMFEBUTAMONE; AMPHETAMINE; ANABOLIC AGENT; ARSENIC; BROMOCRIPTINE; CADMIUM; CAFFEINE; CARBAMAZEPINE; CELECOXIB; CLONIDINE; CLOZAPINE; CYCLOSPORIN; DANAZOL; DISULFIRAM; EPHEDRINE DERIVATIVE; ERGOT ALKALOID; ERYTHROPOIETIN; ETHYLENE GLYCOL; FELODIPINE; FENTANYL; GINGER EXTRACT; GINSENG EXTRACT; GLUCOSAMINE; GLYCYRRHIZA EXTRACT; HYDROCHLOROTHIAZIDE; LEAD; METHYLDOPA; PARACETAMOL; UNINDEXED DRUG;

ADULT; ARTICLE; BLOOD PRESSURE REGULATION; CASE REPORT; CIGARETTE SMOKING; CONSULTATION; DISEASE COURSE; DRUG WITHDRAWAL; FEMALE; HERBAL MEDICINE; HUMAN; HYPERTENSION; KNEE OSTEOARTHRITIS; LEG EDEMA; MONOTHERAPY; OBESITY; PHYSICAL EXAMINATION; POLYPHARMACY; PRESCRIPTION; SPIDER BITE; TACHYCARDIA; URINALYSIS; WELLBEING;

EID: 0037277637     PISSN: 15246175     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1524-6175.2003.01923.x     Document Type: Article

References (33)

1. Pope JE, Anderson JJ, Felson DT. A meta-analysis of the effects of nonsteroidal anti-inflammatory drugs on blood pressure. Arch Intern Med. 1993;153:477-484.
2. Johnson AG, Nguyen TV, Day RO. Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis. Ann Intern Med. 1994;121:289-300.
3. Brook RD, Kramer MB, Blaxall BC, et al. Nonsteroidal anti-inflammatory drugs and hypertension. J Clin Hypertens. 2000;2(5):319-323.
4. Graves JW, Hunder IA. Worsening of hypertension by cyclooxygenase-2 inhibitors. J Clin Hypertens. 2000;2(6):396-398.
5. PDR for Herbal Medicines. 2nd ed. Montvale, NJ: Medical Economics Company; 2000:339-342.
6. Valli G, Giardina EGV. Benefits, adverse effects and drug interactions of herbal therapies with cardiovascular effects. J Am Coll Cardiol. 2002;39:1083-1095.
7. Randin D, Vollenweider P, Tappy L. Suppression of alcohol-induced hypertension by dexamethasone. N Engl J Med. 1995;332:1733-1737.
8. Grossman E, Messerli FH. High blood pressure, a side effect of drugs, poisons, and food. Arch Intern Med. 1995;155:450-460.
9. Hee SA, Jiang H, Whelton PK, et al. The effect of chronic coffee drinking on blood pressure: a meta-analysis of controlled clinical trials. Hypertension. 1999;33:647-652.
10. Klag MJ, Wang NH, Meoni LA, et al. Coffee intake and risk of hypertension. The Johns Hopkins Precursors Study. Arch Intern Med. 2002;162:657-662.
11. Groppelli A, Giorgi DM, Ombroni S, et al. Persistent blood pressure increase induced by heavy smoking. J Hypertens. 1992;10:495-499.
12. Materson BJ, Reda D, Fries ED, et al. Cigarette smoking interferes with treatment of hypertension. Arch Int Med. 1988;148:2116-2119.
13. Bove AA. Dietary supplements in athletes. ACC Curr J Rev. 2002;11:18-20.
14. Samenuk D, Link MS, Houd MK, et al. Adverse cardiovascular events temporarily associated with ma huang, and herbal source of ephedrine. Mayo Clin Proc. 2002;77: 12-16.
15. Haller CA, Benowitz NL. Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids. N Engl J Med. 2000;343:1833-1838.
16. Nies AS, Shand DG. Hypertensive response to propranolol in a patient treated with methyldopa: a proposed mechanism. Clin Pharmacol Ther. 1973;14:923.
17. Roose SP, Dalack GW, Glassman AH, et al. Cardiovascular effects of bypropion in depressed patients with heart disease. Am J Psychiatry. 1991;148:512-516.
18. Carbamazepine, Tegretol. In: Physicians' Desk Reference, 57th ed. Medical Economics Company; 2003:2325.
19. Houston MC. Clonidine hydrochloride. S Med J. 1982;75:713-721.
20. Krentz A. Pseudophaeochromocytoma syndrome associated with clozapine. BMJ. 2001;322:123.
21. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med. 1997;157:2413-2446.
22. Buckner FS, Eschbach JW, Haley R, et al. Hypertension following erythropoietin therapy in anemic hemodialysis patients. Am J Hypertens. 1990;3:947-955.
23. Ruiz F. Fluoxitene and the serotonin syndrome. Ann Emerg Med. 1994;24:983-985.
24. Brem AS. Insights into glucocorticoid-associated hypertension. Am J Kid Dis. 2001;37:1-9.
25. Cattelan AM, Trvenzoli M, Sasset L, et al. Indinacir and systemic hypertension. AIDS. 2001;15:805-807.
26. Rozman B, Praprotnik S, Logar D, et al. Leflunomide and hypertension. Ann Rheum Dis. 2002;51:567-569.
27. Kernan WN, Viscoli CM, Brass LM, et al. Phenylpropanolamine and the risk of hemorrhagic stroke. N Engl J Med. 2000;343:1826-1832.
28. Lloyd-Mostyn RH, Oram S. Modification by propranalol of cardiovascular effects of induced hypoglycemia. Lancet. 1975;1:1213-1215.
29. Drayer J, Keim JH, Weber MA, et al. Unexpected pressor response to propranolol in essential hypertension. Am J Med. 1976;60:987-993.
30. Blum I, Atsmon A, Steiner M. Paradoxical rise in blood pressure during propranolol treatment. BMJ. 1975;1:623.
31. Martin TG. Serotonin syndrome. Ann Emerg Med. 1996;28:520-526.
32. Tangredi JF, Buxton ILO. Hypertension as a complication of topical testosterone therapy. Ann Pharmacother. 2001;35:1205-1207.
33. Meyers BS. Depression and other mood disorders. In: Cobbs EL, Duthie EH, Murphy JB, eds. Geriatric Review Syllabus, 5th ed. Malden, MA; Blackwell Publishing: 2002.